Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Pharmaceutical Outsourcing Present and Future

The need for preclinical testing expertise is growing as molecular complexity increases.

Navigating the Preclinical CRO Outsourcing Process

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

A Closer Look at Affinity Ligands

Topic

Feliza Mirasol is the science editor for 

Articles

Christian Morello, vice president and head of the Bioconjugates Business Unit at Lonza, looks at what is involved in developing modern ADCs. 

A CDMO’s Perspective on Outsourcing Challenges for ADCs–Part 2

Videos

Christian Morello, vice president and head of the Bioconjugates Business Unit at Lonza, discusses the challenges and unmet needs in bringing ADCs to market. 

A CDMO’s Perspective on Outsourcing Challenges for ADCs–Part 1

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Developers save money and time while accessing expertise.

Outsourcing Analytics for Process Monitoring and Optimization

The optimization of processes for the development and manufacture of biopharmaceuticals is pivotal for producing quality products. 

Steps to Process Development Optimization

CDMOs who have integrated technologies can help further the advancement of ADC development.

Advancing ADCs to the Next Level

Pharmaceutical Technology® spoke with Andy Burns, vice president, MDI Business Development at Kindeva, about how sustainability requirements are impacting contract development and manufacturing organizations, specifically for the development and manufacture of inhalation drugs. 

Sustainability in Inhalation and Small-Molecule Drugs

Pharmaceutical Technology® spoke with Saharsh Davuluri, Vice-Chairman and Managing Director, Neuland Laboratories, to see how the push to sustainability is impacting contract manufacturers. 

Sustainability in Pharmaceutical Outsourcing

Pharmaceutical Technology® spoke with Charles Ruban, president and CEO, Verdot, about the focus of moving to sustainability practices in pharmaceutical manufacturing.

Sustainability in Pharmaceutical Manufacturing

Production is set to take place at Samsung Biologics’ Songdo, South Korea, site, and the agreement will run through December 2030, subject to change.

Samsung Biologics Scores Major Manufacturing Deal Worth Over $1.4 Billion with European Pharma Company

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Pharmaceutical Technology chats about the increasing prevalence of challenging APIs in the development pipeline and the hurdles facing formulators and manufacturers as a result of this trend with Jens Schmidt from Lonza.